 Boston, Massachusetts--Newsfile Corp. - October 12, 2021 - Block Leviton is investigating Revance Therapeutics, Inc. NASDAQ: RVNC for potential securities law violations. Investors who have lost money in their Revance Therapeutics, Inc. investment should contact the firm to learn more about how they might recover those losses. For more details, visit is this all about?On October 12, 2021, the U.S. Food and Drug Administration FDA posted Form 483 to its website citing issues... 